PharmaEssentia Corporation (TPE:6446)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
508.00
+10.00 (2.01%)
Aug 14, 2025, 1:30 PM CST

PharmaEssentia Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
169,299204,725114,578143,84078,06524,709
Upgrade
Market Cap Growth
-1.77%78.68%-20.34%84.26%215.94%2.44%
Upgrade
Enterprise Value
149,460184,91594,836140,32277,60321,027
Upgrade
Last Close Price
508.00613.68345.25475.97288.7292.43
Upgrade
PE Ratio
41.9269.04----
Upgrade
Forward PE
21.6941.3631.8969.03--
Upgrade
PS Ratio
13.4021.0322.4449.91118.9144.34
Upgrade
PB Ratio
5.937.454.7811.8518.376.30
Upgrade
P/TBV Ratio
5.997.534.8412.0819.506.68
Upgrade
P/FCF Ratio
86.65121.51----
Upgrade
P/OCF Ratio
54.1980.38----
Upgrade
EV/Sales Ratio
11.8319.0018.5848.69118.2137.73
Upgrade
EV/EBITDA Ratio
39.12100.14----
Upgrade
EV/EBIT Ratio
42.99106.51----
Upgrade
EV/FCF Ratio
76.50109.75----
Upgrade
Debt / Equity Ratio
0.030.040.050.130.130.17
Upgrade
Debt / EBITDA Ratio
0.250.47----
Upgrade
Debt / FCF Ratio
0.480.57----
Upgrade
Asset Turnover
0.410.330.240.270.110.13
Upgrade
Inventory Turnover
1.230.860.480.830.601.15
Upgrade
Quick Ratio
7.249.349.864.372.803.37
Upgrade
Current Ratio
7.719.9410.645.243.493.82
Upgrade
Return on Equity (ROE)
15.04%11.54%-3.46%-16.77%-68.81%-63.10%
Upgrade
Return on Assets (ROA)
7.12%3.72%-5.61%-11.77%-30.08%-25.26%
Upgrade
Return on Capital (ROIC)
7.78%4.05%-6.16%-13.71%-37.72%-29.60%
Upgrade
Return on Capital Employed (ROCE)
11.80%6.10%----
Upgrade
Earnings Yield
2.39%1.45%-0.54%-0.96%-3.60%-7.88%
Upgrade
FCF Yield
1.15%0.82%-1.74%-1.26%-3.24%-6.22%
Upgrade
Dividend Yield
0.22%0.18%----
Upgrade
Buyback Yield / Dilution
-0.68%-3.59%-13.47%-9.24%-7.39%-10.55%
Upgrade
Total Shareholder Return
-0.46%-3.41%-13.47%-9.24%-7.39%-10.55%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.